Literature DB >> 3960404

Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged.

B Marcyniuk, D M Mann, P O Yates.   

Abstract

Serial sectioning of the locus coeruleus (LC) was employed to determine a topographic loss of nerve cells in patients with Alzheimer's disease (AD). Heaviest loss of nerve cells occurred in the central part of the LC which is thought to project to the temporal cortex and hippocampus, whereas least loss of cells occurred in the most rostral and caudal parts, thought to project to frontal and occipital regions of cortex, respectively. Such changes suggest that the primary damage to these nerve cells in AD occurs within their terminal fields and that perikaryal loss follows as a secondary retrograde change.

Entities:  

Mesh:

Year:  1986        PMID: 3960404     DOI: 10.1016/0304-3940(86)90336-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

Review 1.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.

Authors:  Katharine J Liang; Erik S Carlson
Journal:  Neurobiol Learn Mem       Date:  2019-01-07       Impact factor: 2.877

3.  Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.

Authors:  Mary Gannon; Qin Wang
Journal:  Brain Res       Date:  2018-01-04       Impact factor: 3.252

4.  The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis.

Authors:  G Cole; J W Neal; S K Singhrao; B Jasani; G R Newman
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 5.  Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?

Authors:  Jennifer N K Nyarko; Maa O Quartey; Glen B Baker; Darrell D Mousseau
Journal:  Can J Psychiatry       Date:  2018-04-23       Impact factor: 4.356

6.  Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.

Authors:  Paul R Pennington; Zelan Wei; Lewei Rui; Jennifer A Doig; Brett Graham; Kelly Kuski; Geraldine G Gabriel; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

7.  The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.

Authors:  K Jellinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

8.  Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease.

Authors:  Markus Morawski; Maike Hartlage-Rübsamen; Carsten Jäger; Alexander Waniek; Stephan Schilling; Claudia Schwab; Patrick L McGeer; Thomas Arendt; Hans-Ulrich Demuth; Steffen Rossner
Journal:  Acta Neuropathol       Date:  2010-04-10       Impact factor: 17.088

Review 9.  Motor control and aging: links to age-related brain structural, functional, and biochemical effects.

Authors:  Rachael D Seidler; Jessica A Bernard; Taritonye B Burutolu; Brett W Fling; Mark T Gordon; Joseph T Gwin; Youngbin Kwak; David B Lipps
Journal:  Neurosci Biobehav Rev       Date:  2009-10-20       Impact factor: 8.989

10.  Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.

Authors:  Patricia Szot; Allyn Franklin; Cristina Miguelez; Yangqing Wang; Igor Vidaurrazaga; Luisa Ugedo; Carl Sikkema; Charles W Wilkinson; Murray A Raskind
Journal:  Neuropharmacology       Date:  2015-09-08       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.